Cibus Global LLC
Biotechnology
Healthcare
CBUS
41.62 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.35
52 week high
7.10
high
1.38
52 week low
0.00
low
1.34
growth
-66.50 %
previous Close
1.36
P/E ratio
market cap
73.76 M
div yield
0
usd
Jun 2025
qoq
revenue
933 K
-9.77 %
net incoming
-25.37 M
45.89 %
eps
0.00 %
17.56 %
eps surprise
-103.33 %
net profit margin
-2719.40 %
1815.00 %
operating incoming
-17.95 M
56.83 %
net change in cash
12.88 M
40.66 %
cash on hand
36.46 M
54.59 %
cost of revenue
0.00 %
top top